Vasoconstriction

• 

  Subject Areas on Research

  • A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay. 
  • Action of preoptic injections of beta-endorphin on temperature regulation in rabbits. 
  • Activation in the region of parabrachial nucleus elicits neurogenically mediated coronary vasoconstriction. 
  • Activation of EGF receptors mediates pulmonary vasoconstriction induced by residual oil fly ash. 
  • Alterations in serotonergic receptor expression in experimental vein grafts. 
  • Analysis of responses to sarafotoxin 6a and sarafotoxin 6c in the pulmonary vascular bed of the cat. 
  • Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. 
  • Baroreflex regulation of regional blood flow in congestive heart failure. 
  • Baroreflex-mediated cardiovascular responses to hyperbaric oxygen. 
  • Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders. 
  • Behavioral approaches to Raynaud's disease. 
  • Blood-induced arterial segmental spasm. 
  • CT of Gastrointestinal Vasoocclusive Crisis Complicating Sickle Cell Disease. 
  • Carbon monoxide promotes hypoxic pulmonary vascular remodeling. 
  • Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. 
  • Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsivity of rat aortic rings to alpha-adrenergic agents. 
  • Cerebral vasodilation and vasoconstriction associated with acute anxiety. 
  • Characterization of thromboxane receptor blocking effects of SQ 29548 in the feline pulmonary vascular bed. 
  • Combined effect of acute denervation and ischemia on the microcirculation of skeletal muscle. 
  • Comparison of various hemoglobin polyoxyethylene conjugate solutions as resuscitative fluids after hemorrhagic shock. 
  • Contributions of endothelial and neuronal nitric oxide synthases to cerebrovascular responses to hyperoxia. 
  • Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure. 
  • Coronary constriction to angiotensin II is enhanced by endothelial superoxide production in sheep programmed by dexamethasone. 
  • Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction. 
  • Demonstration of coronary artery myogenic vasoconstriction in the awake dog. 
  • Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat. 
  • Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity. 
  • Effect of alpha-adrenergic stimulation on regional contractile function and myocardial blood flow with and without ischemia. 
  • Effect of brief myocardial ischemia on sympathetic coronary vasoconstriction. 
  • Effect of denervation on endothelium-derived relaxing factor-dependent relaxation in the rat cremaster muscle. 
  • Effect of epidural lidocaine on spinal cord blood flow. 
  • Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice. 
  • Effects of pulsatile perfusion on human saphenous vein vasoreactivity: a preliminary report. 
  • Effects of rabbit platelets on vascular smooth muscle cell DNA synthesis. 
  • Efficacy of ethyl nitrite in reversing surgical vasospasm. 
  • Elemental composition of Na pump inhibited rabbit aorta VSM cells by electron probe X-ray microanalysis. 
  • Endothelial dysfunction in cerebral microcirculation during hypothermic cardiopulmonary bypass in newborn lambs. 
  • Endothelial dysfunction in hypercholesterolemia is corrected by L-arginine. 
  • Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. 
  • Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice. 
  • Evidence for myogenic vasomotor activity in the coronary circulation. 
  • Export by red blood cells of nitric oxide bioactivity. 
  • Expression levels of mRNA for Rho A/Rho kinase and its role in isoprostane-induced vasoconstriction of human placental and maternal vessels. 
  • Extremely low birth weight preterm infants lack vasomotor response in relationship to cold body temperatures at birth. 
  • Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. 
  • Functional MRI of the rat somatosensory cortex: effects of hyperventilation. 
  • Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. 
  • Genetic determinants of retinal vascular caliber: additional insights into hypertension pathogenesis. 
  • High-dose, but not low-dose, aspirin impairs anticontractile effect of ticagrelor following ADP stimulation in rat tail artery smooth muscle cells. 
  • Histamine H1 and H2 receptor-mediated vasoreactivity of human internal thoracic and radial arteries. 
  • Hostility, coronary risk, and alpha-adrenergic to beta-adrenergic receptor density ratio. 
  • Human Vascular Microphysiological System for in vitro Drug Screening. 
  • Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses. 
  • Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function. 
  • Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis. 
  • Hypoxia enhances unilateral lung injury by increasing blood flow to the injured lung. 
  • Hypoxia inhibits nitric oxide synthesis in isolated rabbit lung. 
  • Hypoxic vasodilation by red blood cells: evidence for an s-nitrosothiol-based signal. 
  • Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. 
  • Impact of enalapril therapy on in vitro coronary artery responsiveness in pacing-induced heart failure. 
  • In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery. 
  • Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor. 
  • Influence of SQ 29,548 on vasoconstrictor responses in the hindquarters vascular bed of the cat. 
  • Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 
  • Influence of blood pressure on retinal vascular caliber in young children. 
  • Inhaled nitric oxide, right ventricular efficiency, and pulmonary vascular mechanics: selective vasodilation of small pulmonary vessels during hypoxic pulmonary vasoconstriction. 
  • Inhibition of adenosine-1 receptor-mediated preglomerular vasoconstriction in AT1A receptor-deficient mice. 
  • Inhibition of epinephrine-induced vasospasm with adrenoreceptor blockade in the rat cremaster muscle. 
  • Interaction between transient metabolically mediated dilatation and pressure induced constriction in the canine coronary artery. 
  • Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction. 
  • Intracranial and extracranial blood flow during acute anxiety. 
  • Iris arteriolar diameters in hypoxia and hyperoxia: a photographic study in albino guinea pigs. 
  • Licorice-associated reversible cerebral vasoconstriction with PRES. 
  • Management of swimming-induced pulmonary edema. 
  • MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. 
  • Microvascular determinants of blood flow. 
  • Myogenic constriction of human coronary arterioles. 
  • Neurohumoral mechanisms in heart failure: role in pathogenesis, therapy, and drug tolerance. 
  • Nitric oxide in the human respiratory cycle. 
  • Norepinephrine-induced down regulation of alpha 1 adrenergic receptors in cultured rabbit aorta smooth muscle cells. 
  • Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. 
  • Ocular manifestations of preeclampsia. 
  • Opposing hemodynamic effects of substance P on pulmonary vasculature in rabbits. 
  • Pacing-induced heart failure in the dog: evaluation of peripheral vascular alpha-adrenoceptor subtypes. 
  • Pathophysiology of experimental renovascular hypertension. 
  • Perivascular mural cells of the mouse choroid demonstrate morphological diversity that is correlated to vasoregulatory function. 
  • Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. 
  • Phosphodiesterase-5 inhibitors oppose hyperoxic vasoconstriction and accelerate seizure development in rats exposed to hyperbaric oxygen. 
  • Photoacoustic microscopy of microvascular responses to cortical electrical stimulation. 
  • Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. 
  • Physiology of hyperbaric hyperoxia. 
  • Plasma atrial natriuretic factor during chronic thoracic inferior vena caval constriction. 
  • Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. 
  • Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. 
  • Pulmonary vascular and airway responses to endothelin-1 are mediated by different mechanisms in the cat. 
  • Pulmonary vasoconstriction by serotonin is inhibited by S-nitrosoglutathione. 
  • Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillation. 
  • Quinapril--a new angiotensin-converting enzyme inhibitor: an overview. 
  • RGS2: a "turn-off" in hypertension. 
  • Redox activation of intracellular calcium release channels (ryanodine receptors) in the sustained phase of hypoxia-induced pulmonary vasoconstriction. 
  • Reduction of experimental vein graft intimal hyperplasia by ketanserin. 
  • Regional brain blood flow in man during acute changes in arterial blood gases. 
  • Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure. 
  • Relief of blood-induced arterial vasospasm by pharmacologic solutions. 
  • Renal vascular reactivity in mice: AngII-induced vasoconstriction in AT1A receptor null mice. 
  • Responsiveness of vein bypass grafts to stimulation with norepinephrine and 5-hydroxytryptamine. 
  • Retinal arteriolar narrowing predicts 5-year risk of hypertension in Japanese people: the Funagata study. 
  • Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. 
  • S-nitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. 
  • S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. 
  • Scaffold-free, Human Mesenchymal Stem Cell-Based Tissue Engineered Blood Vessels. 
  • Shock wave lithotripsy causes ipsilateral renal injury remote from the focal point: the role of regional vasoconstriction. 
  • Sleep apnea and retinal signs in cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. 
  • Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure. 
  • Systemic hypertension alters vasomotor function in experimental vein grafts. 
  • TRPV4 Is Required for Hypoxic Pulmonary Vasoconstriction. 
  • TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension. 
  • The combination of theophylline and endothelin receptor antagonism improves exercise performance of rats under simulated high altitude. 
  • The contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing. 
  • The desaturation response time of finger pulse oximeters during mild hypothermia. 
  • The effects of ethanol on brain blood flow in awake dogs. 
  • The effects of hyperoxic and hypercarbic gases on tumour blood flow. 
  • The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. 
  • The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation. 
  • The renin-angiotensin-aldosterone system: a specific target for hypertension management. 
  • The vasodilator effects of clevidipine on human internal mammary artery. 
  • Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. 
  • Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death. 
  • Usefulness of retinal microvascular endothelial dysfunction as a predictor of coronary artery disease. 
  • Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS. 
  • Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion. 
  • Vascular effects of ambient pollutant particles and metals. 
  • Vasoconstrictor responses in thromboxane receptor knockout mice: tubuloglomerular feedback and ureteral obstruction. 
  • Vasodilator action of pentoxifylline on microcirculation of rat cremaster muscle. 
  • Vasodilators in the treatment of acute heart failure: what we know, what we don't. 
• 

  Keywords of People

  • Moon, Richard Edward, Professor of Anesthesiology, Medicine, Pulmonary, Allergy, and Critical Care Medicine
  • Palmer, Gregory M., Associate Professor of Radiation Oncology, Radiation Oncology
  • Sparks, Matthew A., Assistant Professor of Medicine, Medicine, Nephrology